Canagliflozin in dogs

Diabetes mellitus is a common endocrine disease in dogs that requires careful monitoring and treatment. Traditionally, diabetes in dogs is controlled with insulin therapy. However, recent studies have shown that additional medications such as canagliflozin, a sodium-glucose cotransporter 2 inhibitor (SGLT2i), may offer promising results in improving glycemic control.

Canagliflozin in dogs Read More »